- Home
- FNLC vs NAUT Comparison
FNLC vs NAUT Comparison
Compare FNLC & NAUT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | FNLC | NAUT |
|---|---|---|
| Founded | 1864 | 2016 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Laboratory Analytical Instruments |
| Sector | Finance | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 288.7M | 245.0M |
| IPO Year | 1999 | N/A |
Fundamental Metrics
Financial Performance| Metric | FNLC | NAUT |
|---|---|---|
| Price | $25.91 | $2.22 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 24.5K | ★ 207.9K |
| Earning Date | 01-21-2026 | 02-26-2026 |
| Dividend Yield | ★ 5.55% | N/A |
| EPS Growth | ★ 18.07 | N/A |
| EPS | ★ 2.81 | N/A |
| Revenue | ★ $88,119,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $9.48 | ★ N/A |
| Revenue Growth | ★ 12.70 | N/A |
| 52 Week Low | $22.11 | $0.62 |
| 52 Week High | $28.60 | $2.54 |
Technical Indicators
Market Signals| Indicator | FNLC | NAUT |
|---|---|---|
| Relative Strength Index (RSI) | 43.22 | 63.16 |
| Support Level | $26.16 | $1.86 |
| Resistance Level | $27.93 | $2.05 |
| Average True Range (ATR) | 0.55 | 0.12 |
| MACD | -0.18 | 0.00 |
| Stochastic Oscillator | 4.64 | 100.00 |
Price Performance
Historical ComparisonAbout FNLC First Bancorp Inc (ME)
First Bancorp Inc is a Damariscotta-based bank holding company providing a range of retail and commercial banking services including deposit accounts and consumer, commercial and mortgage loans. The company provides investment management and private banking services through an operating division of the bank. Its revenues are generally derived from dividends paid to the company by the bank.
About NAUT Nautilus Biotechnolgy Inc.
Nautilus Biotechnology Inc is a development stage life sciences company creating a platform technology for quantifying and unlocking the complexity of the human proteome. The Company transform the field of proteomics by democratizing access to the proteome and enabling fundamental advancements across human health and medicine. Company's products includes: Proteome Analysis System, Reagent Kits, Software and analysis.